Topic: Free Speech

JD Supra Corporate Brief: Marijuana Industry Banks, Moldy Washing Machines, Deferred Prosecution Agreements, Foreign Sanctions Evaders

Go ahead, sign up for email delivery of the JD Supra Corporate Brief. It is Tuesday, after all… The bottom line? Banks should think twice before doing business with a marijuana-related business… (Jay Baris and Oliver Ireland at Morrison & Foerster) Injury or no injury, consumers are free to join class action lawsuits against Whirlpool… Read more »

PFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFTTTT…

(…that’s the sound of your company’s goodwill disappearing, like a punctured tire, after a social media disaster that took mere seconds to unfold.) You’d think companies would know better, right? That they’d develop procedures for approving tweets sent out by third-party vendors under their name, right? That they wouldn’t be so foolish as to allow… Read more »

JD Supra Corporate Brief: Cuban Wins, Rabobank Pays, FDIC Warns, Australia Repeals

This day in legal history: on October 31, 2002, a federal grand jury indicts former Enron CFO Andrew Fastow on 78 counts of wire fraud, money laundering, conspiracy, and obstruction of justice related to the company’s collapse. Scary! Fake Graveyards, Insulting Tombstones, & A Lawsuit Over Free Speech Violations… (Is That Legal?) It took the… Read more »

Employers: 1, NLRB: 0 – Controversial “Poster Rule” Struck Down

Earlier this week, a federal appeals court ruled that the National Labor Relations Board’s “notice poster rule” – which would have required essentially all private sector employers to post a notice informing employees of various rights provided by the National Labor Relations Act – was invalid. The rule has been controversial since it was announced… Read more »

Off-Label Marketing Opinion Sends Warning to Pharmaceutical Companies

“The Ninth Circuit has reopened a door for off-label marketing prosecutions, and it is important to review your compliance and risk management programs in light of this recent decision.” (Sheppard Mullin) Earlier this month, the Ninth Circuit issued an opinion that sends an important warning to pharmaceutical manufacturers: the First Amendment doesn’t protect off-label marketing… Read more »